Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine. Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixe ...
…
continue reading
Stories from diverse, dynamic and fascinating public health nutritionists, dietitians and foodies alike. Inspiring new connections, new ideas and new foodies
…
continue reading
One in three Canadian adults will get shingles at some point in their life. Shingles can be extremely painful, can occur in devastating locations, and can cause debilitating pain that can last months afterwards. Learn about the vaccine that can powerfully reduce the risk of getting shingles here! Learn more: https://drsue.ca/2024/07/should-you-get-…
…
continue reading
1
What are the barriers to use of weight management medication, and how can we overcome them?
6:18
6:18
Play later
Play later
Lists
Like
Liked
6:18
Only a small fraction of people who may benefit from weight management medication are actually being prescribed treatment. What are the barriers to use of weight management medication, and how can we overcome them? Learn more: https://drsue.ca/2024/07/what-are-the-barriers-to-use-of-weight-management-medication-and-how-can-we-overcome-them/ Any med…
…
continue reading
1
Once weekly insulin now available in Canada!
7:13
7:13
Play later
Play later
Lists
Like
Liked
7:13
Once weekly basal (long acting) insulin is now available in Canada - the first country in the world to start using it. Find out more about insulin icodec (Awiqli) here! Learn more: https://drsue.ca/2024/07/once-weekly-insulin-now-available-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended …
…
continue reading
1
Can semaglutide (Ozempic/Wegovy) cause loss of vision?
5:15
5:15
Play later
Play later
Lists
Like
Liked
5:15
A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop? Learn more: https://drsue.ca/2024/07/can-semaglutide-ozemp…
…
continue reading
1
Can Tirzepatide (Mounjaro/Zepbound) treat obstructive sleep apnea?
6:24
6:24
Play later
Play later
Lists
Like
Liked
6:24
There are currently no medications to treat sleep apnea. Could tirzepatide (Zepbound/Mounjaro) treat sleep apnea along with providing weight loss? Learn more: https://drsue.ca/2024/06/can-tirzepatide-mounjaro-zepbound-treat-obstructive-sleep-apnea/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
…
continue reading
1
Preventing or rebuilding muscle loss from weight loss medication: is dietary protein or exercise more important?
7:34
7:34
Play later
Play later
Lists
Like
Liked
7:34
Some people may lose too much muscle with weight loss medication. In preventing or rebuilding lost muscle, which is more important - dietary protein or physical activity? Learn more: https://drsue.ca/2024/06/preventing-or-rebuilding-muscle-loss-from-weight-loss-medication-is-dietary-protein-or-exercise-more-important/ Any medical discussion on this…
…
continue reading
1
Watching blood pressure on weight loss medication - why is this important?
5:23
5:23
Play later
Play later
Lists
Like
Liked
5:23
Elevated weight can be a cause or contributor to hypertension. Why is it so important to watch your blood pressure if you are on weight management medication? Learn more: https://drsue.ca/2024/06/watching-blood-pressure-on-weight-loss-medication-why-is-this-important/ Any medical discussion on this podcast is intended to be of a general nature only…
…
continue reading
1
Obesity: Are environmental chemicals at the center of the storm?
4:37
4:37
Play later
Play later
Lists
Like
Liked
4:37
Obesity: are environmental chemicals at the center of the storm? Find out where these chemicals may reside.... even in our nonstick cookware. Eeew. Learn more: https://drsue.ca/2024/05/obesity-are-environmental-chemicals-at-the-center-of-the-storm/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
…
continue reading
1
Semaglutide: First GLP1 medication proven to provide kidney protection
4:31
4:31
Play later
Play later
Lists
Like
Liked
4:31
We know that GLP1 medications reduce protein in the urine in people with type 2 diabetes and kidney disease, but no study had ever been done to see whether GLP1 treatment could protect kidney function – until now. Learn more: https://drsue.ca/2024/05/semaglutide-first-glp1-medication-proven-to-provide-kidney-protection/ Any medical discussion on th…
…
continue reading
1
Does heart attack and stroke risk go up after stopping GLP1 receptor agonists?
5:44
5:44
Play later
Play later
Lists
Like
Liked
5:44
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped? Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/…
…
continue reading
1
Semaglutide 2.4mg (Wegovy) for weight management – now at Canadian pharmacies!
7:19
7:19
Play later
Play later
Lists
Like
Liked
7:19
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know? Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is n…
…
continue reading
1
What is 'Fair' Allocation of GLP1 based medications during the global shortages?
8:52
8:52
Play later
Play later
Lists
Like
Liked
8:52
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/ Any medical discussion on this podcast is intended to be of …
…
continue reading
1
Foodies in the Field is taking a (short) break
0:50
0:50
Play later
Play later
Lists
Like
Liked
0:50
TRANSCRIPT Hi, Sophie here as usual. This is just a very short piece of audio to let you know that the Foodies podcast will be taking a bit of a holiday until the later half of this year. As keen listeners will know, I’m undertaking a PhD at the moment as well as working a part time job. The PhD is coming to the pointy end which means my time and b…
…
continue reading
1
How much does sleep apnea improve with weight loss - and does it matter how the weight is lost?
5:29
5:29
Play later
Play later
Lists
Like
Liked
5:29
As many as 1 BILLION adults worldwide are estimated to have obstructive sleep apnea (OSA), and 70% of people with OSA have obesity. How much does sleep apnea improve with weight loss, and does it matter how the weight is lost (with lifestyle, weight management medication, or bariatric surgery)? Learn more: https://drsue.ca/2024/04/how-much-does-sle…
…
continue reading
1
Weight management medication semaglutide (Wegovy) for heart failure - what do new data in people with diabetes teach us?
4:52
4:52
Play later
Play later
Lists
Like
Liked
4:52
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us? Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/ Any medical discussion on this podca…
…
continue reading
1
How many people with obesity actually receive prescriptions for weight management medication?
4:13
4:13
Play later
Play later
Lists
Like
Liked
4:13
Older data have shown that obesity medications are prescribed far less frequently than medications for other chronic medical conditions. Much has changed in recent years in the weight management world. How has this impacted prescribing of weight management medication? Learn more: https://drsue.ca/2024/04/how-many-people-with-obesity-actually-receiv…
…
continue reading
1
‘Mounjaro/Ozempic Babies’ in the media: What you need to know
5:34
5:34
Play later
Play later
Lists
Like
Liked
5:34
Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know? Learn more: https://drsue.ca/2024/04/mounjaro-ozemp…
…
continue reading
1
Ultra-processed foods are killing us and the planet, with Kim Anastasiou
52:14
52:14
Play later
Play later
Lists
Like
Liked
52:14
In this episode Kim Anastasiou, a Research Fellow at the Stretton Health Equity Institute of the University of Adelaide, unpacks the impact that ultra processed foods are having not just on our health but also our environment and what this means for the work we do and the world we live in. Kim is an advocate for the transformative changes needed to…
…
continue reading
1
What will the Oprah Effect be on obesity medicine?
4:45
4:45
Play later
Play later
Lists
Like
Liked
4:45
Oprah Winfrey recently hosted a special called 'Shame, Blame, and the Weight Loss Revolution'. What will the Oprah Effect be on obesity medicine? Learn more: https://drsue.ca/2024/03/what-will-the-oprah-effect-be-on-obesity-medicine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian au…
…
continue reading
1
First medication ever approved to treat fatty liver disease - how will GLP1 based obesity/diabetes medications stack up?
7:21
7:21
Play later
Play later
Lists
Like
Liked
7:21
Resmetirom is the first treatment ever approved for fatty liver disease. Could GLP1 based obesity/diabetes medications have similar benefits? Learn more: https://drsue.ca/2024/03/first-medication-ever-approved-to-treat-fatty-liver-disease-how-will-glp1-based-obesity-diabetes-medications-stack-up/ Any medical discussion on this podcast is intended t…
…
continue reading
1
How can we diagnose sarcopenia (excessive loss of muscle) in people successfully losing weight?
4:15
4:15
Play later
Play later
Lists
Like
Liked
4:15
With the emergence of medications that are very powerful for weight loss, some people may lose too much weight. This can include excessive loss of muscle mass, a condition called sarcopenia. How should we look for and diagnose sarcopenia? Learn more: https://drsue.ca/2024/03/how-can-we-diagnose-sarcopenia-excessive-loss-of-muscle-in-people-successf…
…
continue reading
1
Diabetes remission: should we ‘DiRECT’ patients towards lifestyle change alone?
5:53
5:53
Play later
Play later
Lists
Like
Liked
5:53
The DiRECT 5 year trial of diabetes remission with lifestyle was just published. Does this study suggest that we should 'DiRECT' our patients towards lifestyle treatment alone? Learn more: https://drsue.ca/2024/03/diabetes-remission-should-we-direct-patients-towards-lifestyle-change-alone/ Any medical discussion on this podcast is intended to be of…
…
continue reading
1
Is diabetes remission with lifestyle change a realistic long term goal?
5:59
5:59
Play later
Play later
Lists
Like
Liked
5:59
Guidelines currently recommend lifestyle change as a strategy to achieve diabetes remission. But is diabetes remission with lifestyle change alone a realistic long term goal? Learn more: https://drsue.ca/2024/02/is-diabetes-remission-with-lifestyle-change-a-realistic-long-term-goal/ Any medical discussion on this podcast is intended to be of a gene…
…
continue reading
1
Dr. Fiona Willer on reducing weight stigma in community health
1:03:37
1:03:37
Play later
Play later
Lists
Like
Liked
1:03:37
Dr. Fiona Willer is an Advanced Accredited Practising Dietitian and Fellow of the Higher Education Academy renowned for her advocacy of weight-neutral practices in healthcare. Throughout the podcast episode, Fiona shares insights on why a weight neutral approach is necessary to progress population wellbeing, and how community health and food practi…
…
continue reading
1
Will glucagon with GLP-1 be a new combination weight management treatment?
4:53
4:53
Play later
Play later
Lists
Like
Liked
4:53
Will glucagon with GLP-1 be a new combination weight management treatment? How could these 2 hormones work together to facilitate weight loss? Learn more: https://drsue.ca/2024/02/will-glucagon-with-glp1-be-a-new-combination-weight-management-treatment/ Any medical discussion on this podcast is intended to be of a general nature only, and is intend…
…
continue reading
1
Could Spending More Time At A ‘Target’ Weight Protect Against Kidney Failure In People With Type 2 Diabetes?
4:47
4:47
Play later
Play later
Lists
Like
Liked
4:47
There are many important strategies to protect the kidneys of people with type 2 diabetes. Could a longer time at a target weight loss be one of them? Learn more: https://drsue.ca/2024/02/could-spending-more-time-at-a-target-weight-protect-against-kidney-failure-in-people-with-type-2-diabetes/ Any medical discussion on this podcast is intended to b…
…
continue reading
1
UPDATE - Are weight management and diabetes GLP1 medications associated with suicide risk?
5:48
5:48
Play later
Play later
Lists
Like
Liked
5:48
Rare post marketing case reports of suicidality have emerged amongst people taking GLP1 receptor agonists for diabetes or obesity. What new data do we have on this, and where are global regulatory agencies at in their investigations? Learn more: https://drsue.ca/2024/01/update-are-glp1-receptor-agonist-medications-for-weight-management-and-diabetes…
…
continue reading
What are the risks associated with the RSV virus, and should you be vaccinated? Learn more: https://drsue.ca/2024/01/should-you-get-the-rsv-vaccine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor…
…
continue reading
1
Why do so many people stop weight management medication
7:34
7:34
Play later
Play later
Lists
Like
Liked
7:34
Why do so many people stop weight management medication - and why does it matter? Learn more: https://drsue.ca/2024/01/why-do-so-many-people-stop-their-weight-management-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specifi…
…
continue reading
1
Does elevated weight increase risk of autoimmune type 1 diabetes
4:24
4:24
Play later
Play later
Lists
Like
Liked
4:24
We know that elevated weight is a key risk factor for developing type 2 diabetes. Does carrying elevated weight increase the risk of developing autoimmune type 1 diabetes as well? Learn more: https://drsue.ca/2024/01/does-obesity-increase-the-risk-of-developing-autoimmune-type-1-diabetes/ Any medical discussion on this podcast is intended to be of …
…
continue reading
Weight management medications are expensive, and often on shortage. What happens if we treat intermittently (on and off)? Learn more: https://drsue.ca/2023/12/should-we-consider-on-off-intermittent-treatment-with-weight-loss-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian…
…
continue reading
Could Alexa AI help people titrate insulin (for diabetes) or GLP1 receptor agonists (for diabetes or weight management)? Learn more: https://drsue.ca/2023/12/could-ai-help-to-optimize-insulin-or-glp1-receptor-agonist-therapy/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. …
…
continue reading
Miss any key advancements and challenges in the field of weight management in 2023? Join me for the highlights here! Learn more: https://drsue.ca/2023/12/dr-sues-weight-management-highlights-2023/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed …
…
continue reading
Just how does obesity increase the risk of so many types of cancer? Learn more: https://drsue.ca/2023/12/how-does-obesity-increase-cancer-risk/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to t…
…
continue reading
Could we detect diabetes with nothing more than a smart phone and internet access? Voice has emerged as a potential candidate for detecting diabetes, with AI technology being explored as a screening tool. Learn more: https://drsue.ca/2023/11/could-ai-detect-diabetes-by-listening-to-your-voice/ Any medical discussion on this podcast is intended to b…
…
continue reading
Many women with polycystic ovary syndrome struggle with elevated weight. What do the new guidelines say about weight management? Learn more: https://drsue.ca/2023/11/polycystic-ovary-syndrome-pcos-what-do-the-new-guidelines-say-about-weight-management/ Any medical discussion on this podcast is intended to be of a general nature only, and is intende…
…
continue reading
1
Treat to target weight management medication
7:22
7:22
Play later
Play later
Lists
Like
Liked
7:22
With new and emerging evidence for the benefits of weight management medication far beyond simply weight loss, should we reframe and fine tune our targets further? Learn more: https://drsue.ca/2023/11/weight-management-what-does-it-mean-to-treat-to-target-with-medication/ Any medical discussion on this podcast is intended to be of a general nature …
…
continue reading
Tirzepatide (Mounjaro) is very effective for improvement in blood sugar control and weight loss. Find out about this exciting new addition to Canada's treatment options for type 2 diabetes. Learn more: https://drsue.ca/2023/10/tirzepatide-now-available-in-canada-how-to-with-vial-and-syringe/ Any medical discussion on this podcast is intended to be …
…
continue reading
Why are there shortages of weight management medication? Should use of diabetes-labeled treatments be denied to people with obesity without diabetes? What does the shortage mean for socioeconomic disparities in health? Learn more: https://drsue.ca/2023/10/shortages-of-weight-management-medication/ Any medical discussion on this podcast is intended …
…
continue reading
What's new with the Freestyle Libre (2 and 3), the Dexcom (G7), and the Medtronic (Guardian 4) in Canada? Learn more: https://drsue.ca/2023/10/advances-in-blood-sugar-monitoring-technology-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not design…
…
continue reading
Is fat under the skin (subcutaneous) really healthy? Does cutting back food intake by 500 calories per day really result in 1 pound of weight loss per week? Find out the answers to these questions and more! Learn more: https://drsue.ca/2023/09/30-myths-about-obesity-part-1/ Any medical discussion on this podcast is intended to be of a general natur…
…
continue reading
Does every pound of muscle that replaces fat really burn an extra 50 calories per day? Is slow, gradual weight loss really better than losing a large amount quickly? Find out the answers to these questions and more! Learn more: https://drsue.ca/2023/10/30-myths-about-obesity-part-2/ Any medical discussion on this podcast is intended to be of a gene…
…
continue reading
What are cravings exactly? And what tools do we have available to combat them? Learn more: https://drsue.ca/2023/09/what-are-cravings-and-how-can-we-reduce-them/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to …
…
continue reading
Semaglutide 2.4mg (Wegovy) is the first weight management medication ever to show that it reduces cardiovascular events. Read more about this here! Learn more: https://drsue.ca/2023/11/semaglutide-wegovy-first-weight-management-medication-in-the-world-to-show-reduction-in-cardiovascular-events/ Any medical discussion on this podcast is intended to …
…
continue reading
1
'Yhunger' a food literacy program for youth by youth, with Rowena Yamazaki
1:01:00
1:01:00
Play later
Play later
Lists
Like
Liked
1:01:00
Rowena Yamazaki is an Accredited Practicing Dietitian from YouthBlock - a specialist youth health service in Sydney. For the last 17 years Rowena has led the Yhunger program which aims to strengthen young people's food literacy skills and improve their food security status. Rowena talks about involving youth throughout all elements of food and nutr…
…
continue reading
1
Is Australia really the lucky country? The who, what, why and how to address food insecurity, with Dr. Sue Kleve
1:02:05
1:02:05
Play later
Play later
Lists
Like
Liked
1:02:05
Dr. Sue Kleve is a public health nutrition researcher and senior lecturer with the Department of Nutrition, Dietetics and Food at Monash University. Sue has over 20 years’ experience working across community and public health nutrition settings in Australia. In this episode Sue provides insights into why more and more Australians are experiencing f…
…
continue reading
1
Interrogating the Health Star Rating, with Dr. Alexandra Jones
59:59
59:59
Play later
Play later
Lists
Like
Liked
59:59
Dr Alexandra Jones is a public health lawyer and researcher at The George Institute for Global Health within the Food Policy team. This episode dives deep into the world of food policy and regulation, as Ali explains Front of Pack Labelling around the world with a particular focus on the Australian Health Star Rating. We talk about how this regulat…
…
continue reading
1
What is food literacy and why is it important?, with Assoc. Prof. Helen Vidgen
49:02
49:02
Play later
Play later
Lists
Like
Liked
49:02
Helen Vidgen is an Associate Professor in Nutrition and Dietetics at the Queensland University of Technology. This is Part Two of a two-part episode. This episode is all about Helen’s food literacy work and the global impact that it's had.If you’re unsure what food literacy is, why we should be considering it in our everyday work and how we can do …
…
continue reading
1
Hacking the nutrition job market, with Assoc. Prof. Helen Vidgen
52:58
52:58
Play later
Play later
Lists
Like
Liked
52:58
Helen Vidgen is an Associate Professor in Nutrition and Dietetics at the Queensland University of Technology. This is Part One of a Two-part episode. In this first episode we go through Helen’s incredible career journey in public health and community nutrition and dive deep into various topics including the lack of diversity in our workforce, how t…
…
continue reading
1
Saving the World, with Professor Sharon Friel
53:44
53:44
Play later
Play later
Lists
Like
Liked
53:44
Professor Sharon Friel is an ARC Laureate Fellow, Professor of Health Equity and Director of the Planetary Health Equity Hothouse and the Menzies Centre for Health Governance at the School of Regulation and Global Governance (RegNet) at the Australian National University. On today’s show Sharon talks about investigating the intersection of climate …
…
continue reading